Latest filing published 15 Sept 2021 for 华兰生物, €1.2M.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -34.6%Entry CN¥27.78 · Close at T+365 CN¥18.18
- -32.9%Entry CN¥29.43 · Close at T+365 CN¥19.76
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
安康: trading record in brief
This profile gathers the share dealings of 安康 in 华兰生物, where the filings describe the role as chief executive. Over a trading history stretching from 30 August 2021 to 15 September 2021, the count stands at 2 filings.
The open-market record is one-sided, with 2 purchases worth €3.2M and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
On 15 September 2021 came the latest disclosure, an open-market purchase for €1.2M in 华兰生物. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Companies and markets linked to 安康
Open company profiles for insider transactions, fundamentals and analyst consensus when available.